Back to results
CompletedPhase 1

Safety, Tolerability, and Pharmacokinetics Study of NDX-1017

NCT03298672

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Biotrial Inc.

Newark, New Jersey, United States

View on ClinicalTrials.gov
Safety, Tolerability, and Pharmacokinetics Study of NDX-1017 — TrialFind